002007.SZ SHZ
Hualan Biological Engineering Inc.
1W: +0.5%
1M: +2.0%
3M: +4.7%
YTD: -14.3%
1Y: -17.2%
3Y: -35.9%
5Y: -61.1%
¥13.34 ($1.99)
+0.32 (+2.46%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$15.3B
-6.4% ▼
5Y CAGR: +8.7%
Total Liabilities
$1.8B
-26.4% ▼
5Y CAGR: -1.3%
Shareholders Equity
$11.5B
-3.0% ▼
5Y CAGR: +8.8%
Cash & Investments
$4.3B
+32.2% ▲
5Y CAGR: +1.3%
Total Debt
$547M
-39.8% ▼
5Y CAGR: +6.5%
Net Debt
-$228M
+50.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $693M | $1.1B | $994M | $1.4B | $775M |
| Short-Term Investments | $2.7B | $2.4B | $2.1B | $1.9B | $3.5B |
| Cash & ST Investments | $3.4B | $3.5B | $3.1B | $3.3B | $4.3B |
| Net Receivables | $2.1B | $2.4B | $2.6B | $2.1B | $2.1B |
| Inventory | $1.4B | $1.4B | $1.7B | $2.0B | $2.3B |
| Other Current Assets | $44M | $753M | $2.0B | $2.2B | $100M |
| Total Current Assets | $6.9B | $8.1B | $9.3B | $9.6B | $8.9B |
| Property, Plant & Equip. | $2.3B | $2.3B | $2.9B | $3.0B | $3.1B |
| Goodwill & Intangibles | $228M | $335M | $347M | $347M | $342M |
| Long-Term Investments | -$2.6B | -$2.3B | $3.3B | $3.0B | $2.8B |
| Other Non-Current Assets | $4.5B | $6.1B | $33M | $126M | $27M |
| Total Non-Current Assets | $4.7B | $6.7B | $6.8B | $6.7B | $6.4B |
| Total Assets | $11.5B | $14.7B | $16.1B | $16.3B | $15.3B |
| — Liabilities — | |||||
| Accounts Payable | $241M | $175M | $197M | $217M | $188M |
| Short-Term Debt | $811M | $800M | $1.0B | $900M | $539M |
| Deferred Revenue | $1.2B | $15M | $0 | $0 | $10M |
| Other Current Liabilities | $248K | $882K | $1.3B | $87M | $1.0B |
| Total Current Liabilities | $2.2B | $2.1B | $2.6B | $2.4B | $1.8B |
| Long-Term Debt | $190M | $300M | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $51M | $0 | $0 |
| Total Non-Current Liabilities | $258M | $382M | $103M | $103M | $17M |
| Total Liabilities | $2.5B | $2.5B | $2.7B | $2.5B | $1.8B |
| — Equity — | |||||
| Common Stock | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B |
| Retained Earnings | $5.8B | $6.4B | $7.3B | $7.7B | $7.4B |
| Accumulated OCI | $715M | $2.1B | $0 | $0 | $2.3B |
| Total Stockholders Equity | $8.3B | $10.4B | $11.4B | $11.9B | $11.5B |
| Total Liabilities & Equity | $11.5B | $14.7B | $16.1B | $16.3B | $15.3B |
| — Key Metrics — | |||||
| Total Debt | $1.0B | $1.1B | $1.0B | $909M | $547M |
| Net Debt | $308M | $11M | $16M | -$458M | -$228M |
| Total Investments | $96M | $70M | $5.4B | $4.9B | $6.3B |